Additionally, CLDN6 interacts with LATS1/2 to reduce LATS1/2 and YAP1 phosphorylation, influence YAP1 entry into the nucleus, and enhance the invasive ability of gastric cancer cells (45, 144). This evidence concerns the gene CLDN6 and gastric cancer.